BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31880526)

  • 21. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors].
    Shan XY; Chen BA; Xia GH; Xu WL; Ding JH; Gao C; Sun YY; Wang J; Cheng J; Zhao G; Bao W; Song HH; Gao F; Wang F; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):90-5. PubMed ID: 20137125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reversal of multidrug resistance by lomerizine in K562/ADM cells].
    Zhu HJ; Wu YL; Liu GQ
    Yao Xue Xue Bao; 2004 May; 39(5):333-7. PubMed ID: 15338873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02].
    Liang H; Zhang Y; Zhang JD; Gu J; Ma L; Wang XL; Shen WG
    Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):647-50. PubMed ID: 17997939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
    Zhao D; Jiang Y; Dong X; Liu Z; Qu B; Zhang Y; Ma N; Han Q
    Biomed Pharmacother; 2011 Aug; 65(5):354-8. PubMed ID: 21775093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osthole shows the potential to overcome P-glycoprotein‑mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Wang JY; Li YJ
    Oncol Rep; 2016 Jun; 35(6):3659-68. PubMed ID: 27109742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reversal effect of gambogic acid on multidrug resistance of K562/A02 cell line].
    Tian L; Liu J; Chen BA; Cheng J; Ding JH; Wang S; Xia GH; Gao F; Shao ZY; Zhang HJ; Guo QL; Zhang HW; Wang L; Ren YY; Cai XH; Liu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):252-7. PubMed ID: 22541076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDR reversal activity of bromotetrandrine in vitro and in vivo.
    Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of triptolide on sensitivity of K562/A02 cell line to adriamycin].
    Hui LL; Xu WL; Chen QY; Zhu XL; Long LL; Xu Y; Qing R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):66-9. PubMed ID: 22391167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance.
    Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P
    Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
    Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents.
    Jiao L; Qiu Q; Liu B; Zhao T; Huang W; Qian H
    Bioorg Med Chem; 2014 Dec; 22(24):6857-66. PubMed ID: 25464884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
    Cheng J; Wu W; Chen BA; Gao F; Xu W; Gao C; Ding J; Sun Y; Song H; Bao W; Sun X; Xu C; Chen W; Chen N; Liu L; Xia G; Li X; Wang X
    Int J Nanomedicine; 2009; 4():209-16. PubMed ID: 19918367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethyl lucidenates A reverses P-glycoprotein mediated vincristine resistance in K562/A02 cells.
    Li P; Chen SY; Shen SX; Liu LX; Xu JH; Zhang ZQ
    Nat Prod Res; 2019 Mar; 33(5):732-735. PubMed ID: 29130339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
    Chen H; Wang J; Zhang J; Wang Y; Cao B; Bai S; Yu PF; Bi W; Xie W
    Biol Pharm Bull; 2009 Apr; 32(4):609-13. PubMed ID: 19336892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line.
    Cheng J; Cheng L; Chen B; Xia G; Gao C; Song H; Bao W; Guo Q; Zhang H; Wang X
    Int J Nanomedicine; 2012; 7():2843-52. PubMed ID: 22745547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
    Pan J; Miao D; Chen L
    Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
    Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
    Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.